Factors that predict response and disease free survival in clinically advanced follicular lymphomas.

被引：0
|
作者：
Genua, A
Biscottini, B
Cinieri, S
Trottini, M
DeRenzo, A
Rotoli, B
Tafuto, S
Abate, G
Milani, S
Mustacchi, G
Ambrosi, L
Leoni, P
Mastria, A
Lorusso, V
Vecchi, A
Sacchi, S
Palmieri, F
Volpe, E
Azzolini, C
Dammacco, F
DiCostanzo, F
Caparrotti, G
Grignani, F
DeANgelis, V
AlSharjaby, N
Liberati, AM
机构：
[1] IST TUMORI NAPOLI,EMAT NAPOLI,TRIESTE,ITALY
[2] IMISO,PERUGIA,ITALY
[3] ONCOL,BARI,ITALY
[4] EMAT,ANCONA,ITALY
[5] EMAT,AVELLINO,ITALY
[6] MED CLIN,MODENA,ITALY
[7] DIMO,BARI,ITALY
[8] ONCOL,TERNI,ITALY
[9] EMAT,CASERTA,ITALY
来源：
BLOOD | 1997年 / 90卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：842 / 842
页数：1
相关论文
共 50 条
  • [21] A doxorubicin containing regimen with or without interferon alpha 2b (IFN alpha 2b) in advanced follicular lymphomas. Final analysis of survival, toxicity and quality of life of the GELF86 trial.
    SolalCeligny, P
    Lepage, E
    Brousse, N
    Tertian, G
    Thyss, A
    Reman, O
    Sebban, C
    Pignon, B
    Gisselbrecht, C
    Coiffier, B
    Cole, B
    Sugano, D
    Tendler, C
    BLOOD, 1996, 88 (10) : 1800 - 1800
  • [22] Patterns of regional lymph node metastasis predict postoperative overall survival and disease-free survival in locally advanced esophageal squamous cell carcinoma
    Xu, Haijie
    Huang, Shujie
    Chen, Jianrong
    Lin, Xirui
    Dong, Yuejiao
    Hong, Liangli
    Xie, Zefeng
    Wu, Hansheng
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2024, 15 (04)
  • [23] MGMT expression levels predict disease stabilisation, progression-free and overall survival in patients with advanced melanomas treated with DTIC
    Busch, Christian
    Geisler, Jurgen
    Lillehaug, Johan R.
    Lonning, Per Eystein
    EUROPEAN JOURNAL OF CANCER, 2010, 46 (11) : 2127 - 2133
  • [24] Therapeutic Cancer Vaccine Significantly Prolongs Disease-Free Survival for Follicular Lymphoma
    不详
    ONCOLOGY-NEW YORK, 2009, 23 (07): : 642 - 642
  • [25] STAGE, SERUM LDH, AND PERFORMANCE STATUS PREDICT DISEASE PROGRESSION AND SURVIVAL IN HIV-ASSOCIATED LYMPHOMAS
    HAGEMEISTER, FB
    KHETAN, R
    ALLEN, P
    MCLAUGHLIN, P
    RODRIGUEZ, MA
    SWAN, F
    ROMAGUERA, JE
    CABANILLAS, F
    ANNALS OF ONCOLOGY, 1994, 5 : S41 - S46
  • [26] Response, disease-free survival, and overall survival: What matters for whom?
    Dittrich, C.
    EUROPEAN SURGERY-ACTA CHIRURGICA AUSTRIACA, 2010, 42 (01): : 5 - 7
  • [27] The intensification of beam conditioning doesn't influence both event-free survival (EFS) and overall survival (OS) of patients transplanted for non-Hodgkin's malignant lymphomas.
    Trneny, M
    Benesová, K
    Slaby, J
    Apltauerová, M
    Procházka, B
    Kobylka, P
    Klener, P
    BONE MARROW TRANSPLANTATION, 1998, 21 : S178 - S178
  • [28] Kappa Free Light Chains Index Predict Disease Course in Clinically and Radiologically Isolated Syndromes
    Levraut, Michael
    Gavoille, Antoine
    Landes-Chateau, Cassandre
    Cohen, Mikael
    Bresch, Saskia
    Seitz-Polski, Barbara
    Mondot, Lydiane
    Lebrun-Frenay, Christine
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 302 - 302
  • [29] FACTORS INFLUENCING DISEASE FREE SURVIVAL AFTER RADICAL PROSTATECTOMY
    HERING, F
    RIST, M
    BIEDERMANN, C
    CHOLET, D
    MIHATSCH, M
    CHATELANAT, F
    RUTISHAUSER, G
    GRABER, P
    JOURNAL OF UROLOGY, 1986, 135 (04): : A242 - A242
  • [30] Disease-free survival related factors in breast cancer
    Davila-Arias, Cristina
    Ocon, Olga
    Fernandez, Mariana F.
    Pedro Arrebola, Juan
    Jose Sanchez, Maria
    Aneiros, Jose
    Torne, Pablo
    Olea, Nicolas
    MEDICINA CLINICA, 2014, 143 (07): : 293 - 299
12345